{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:01:11Z","timestamp":1793721671368,"version":"4.6.1"},"reference-count":149,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Harrow Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/17425247.2025.2522947","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T08:33:24Z","timestamp":1750322004000},"page":"1359-1374","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["All eyes on semifluorinated alkanes: a comprehensive review of the influence of semifluorinated alkane eyedrops on tear film stabilization and drug delivery in dry eye disease"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3831-3833","authenticated-orcid":false,"given":"Priyanka","family":"Agarwal","sequence":"first","affiliation":[{"name":"University of Auckland","place":["Auckland, New Zealand"]},{"name":"TheiaNova Ltd","place":["Auckland, New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Epitropoulos","sequence":"additional","affiliation":[{"name":"The Eye Center of Columbus","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Gaddie","sequence":"additional","affiliation":[{"name":"Gaddie Eye Centers","place":["Louisville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-6155","authenticated-orcid":false,"given":"Anat","family":"Galor","sequence":"additional","affiliation":[{"name":"University of Miami","place":["Miami, USA"]},{"name":"Miami Veterans Affairs Medical Center","place":["Miami, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Karpecki","sequence":"additional","affiliation":[{"name":"Kentucki Eye Associates","place":["Lexington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Schmidt","sequence":"additional","affiliation":[{"name":"St. Louis University School of Medicine","place":["St. Louis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.008"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000998"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00671.x"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000134183.47687.75"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0915"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40135-013-0009-1"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.01.026"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.103"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288523"},{"issue":"3","key":"e_1_3_4_12_1","first-page":"264","article-title":"Determination of tear volume and tear flow","volume":"5","author":"Mishima S","year":"1966","unstructured":"Mishima S, Gasset A, Klyce SD, et al. Determination of tear volume and tear flow. Invest Ophthalmol Visual Sci. 1966 Jun 1;5(3):264\u2013276.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1975.01010020291009"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997a"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307415"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e3181bc63cc"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70299-9"},{"key":"e_1_3_4_19_1","first-page":"349","article-title":"Meibomian gland lipids, evaporation, and tear film stability. Lacrimal gland, tear film, and dry eye syndromes 2","volume":"1","author":"Mathers WD","year":"1998","unstructured":"Mathers WD, Lane JA. Meibomian gland lipids, evaporation, and tear film stability. Lacrimal gland, tear film, and dry eye syndromes 2. Basic Sci Clin Relevance. 1998 Jan;1:349\u2013360.","journal-title":"Basic Sci Clin Relevance"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2005.12.035"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70139-8"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2007.04.009"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.08.075"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2003.09.019"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-16607"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11878"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-16490"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2013.05.003"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e318193f4fc"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10487"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1006\/jcis.1998.5756"},{"issue":"3","key":"e_1_3_4_32_1","first-page":"374","article-title":"Tear film osmolarity and ocular surface disease in two rabbit models for keratoconjunctivitis sicca","volume":"29","author":"Gilbard JP","year":"1988","unstructured":"Gilbard JP, Rossi SR, Gray KL, et al. Tear film osmolarity and ocular surface disease in two rabbit models for keratoconjunctivitis sicca. Invest Ophthalmol Visual Sci. 1988 Mar 1;29(3):374\u2013378.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.156.15.485"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31821de383"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1201\/b14144-4"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2020.08.004"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2017.09.013"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e318283dfc6"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20200519-01"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.004"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2024.0103"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2015.0071"},{"issue":"1","key":"e_1_3_4_43_1","first-page":"90","article-title":"Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A","volume":"42","author":"Brignole F","year":"2001","unstructured":"Brignole F, Pisella PJ, De Saint Jean M, et al. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Visual Sci. 2001 Jan 1;42(1):90\u20135.111.","journal-title":"Invest Ophthalmol Visual Sci"},{"issue":"11","key":"e_1_3_4_44_1","first-page":"3943","article-title":"Traffic of major histocompatibility complex class II molecules in rabbit lacrimal gland acinar cells","volume":"35","author":"Mircheff AK","year":"1994","unstructured":"Mircheff AK, Gierow JP, Wood RL. Traffic of major histocompatibility complex class II molecules in rabbit lacrimal gland acinar cells. Invest Ophthalmol Visual Sci. 1994 Oct 1;35(11):3943\u20133951.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5359-5_75"},{"issue":"1","key":"e_1_3_4_46_1","first-page":"28","article-title":"Regulation of human leukocyte antigen expression in human conjunctival epithelium","volume":"40","author":"Tsubota K","year":"1999","unstructured":"Tsubota K, Fukagawa K, Fujihara T, et al. Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Visual Sci. 1999 Jan 1;40(1):28\u201334.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2024.10.003"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199811000-00002"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S1409"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.10.023"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.006"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000214802.40313.fa"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000240079.24583.a1"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000569"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2010.498657"},{"issue":"3","key":"e_1_3_4_56_1","first-page":"653","article-title":"Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model","volume":"42","author":"Moore CP","year":"2001","unstructured":"Moore CP, McHugh JB, Thorne JG, et al. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model. Invest Ophthalmol Visual Sci. 2001 Mar 1;42(3):653\u2013659.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11681"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.3.330"},{"issue":"2","key":"e_1_3_4_59_1","first-page":"377","article-title":"Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL\/Mp-lpr\/lpr mice","volume":"37","author":"Jabs DA","year":"1996","unstructured":"Jabs DA, Lee B, Burek CL, et al. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL\/Mp-lpr\/lpr mice. Invest Ophthalmol Visual Sci. 1996 Feb 1;37(2):377\u2013383.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002244"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-016-3572-y"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-024-04154-4"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/604204"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00176-1"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.8.1046"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31823cc098"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.7.5.24"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S442971"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2018.04.09"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.04.002"},{"issue":"7","key":"e_1_3_4_71_1","first-page":"1362","article-title":"Ocular penetration of cyclosporin A. The rabbit eye","volume":"31","author":"BenEzra D","year":"1990","unstructured":"BenEzra D, Maftzir G. Ocular penetration of cyclosporin A. The rabbit eye. Invest Ophthalmol Visual Sci. 1990 Jul 1;31(7):1362\u20131366.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070060132063"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0229"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114867"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S184412"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-018-2556-5"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2011.25.6.369"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000779"},{"issue":"7","key":"e_1_3_4_79_1","first-page":"115","article-title":"Effect of cyclosporine ophthalmic solution 0.09% on conjunctival staining in patients with keratoconjunctivitis sicca","volume":"61","author":"Ogundele AB","year":"2020","unstructured":"Ogundele AB, Karpecki P, Devries D, et al. Effect of cyclosporine ophthalmic solution 0.09% on conjunctival staining in patients with keratoconjunctivitis sicca. Invest Ophthalmol Visual Sci. 2020 Jun 10;61(7):115.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S175065"},{"key":"e_1_3_4_81_1","unstructured":"Cequa USPI Sun Ophthalmics. 2018 [cited 2025 Jan 14]."},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2023.05.00581"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.01.01982"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2019.02.010"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2007.11.002"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210001000301"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1021\/jp201364k"},{"key":"e_1_3_4_88_1","unstructured":"Meinert H. inventor; Novaliq GmbH assignee. Inhalative and instillative use of semifluorinated alkanes as an active substance carrier in the intrapulmonary area. United States patent US 8 986 738. 2015 Mar 24."},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.3109\/10731199309117383"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.3109\/10731199209117860"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.03.037"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1006\/jcis.1994.1118"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1021\/la036381m"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2003.01206.x"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199602000-00016"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.10.051"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2010.05.011"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.143750"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.7.921"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210201200614"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/956831"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.2174\/1566524017666170807144009"},{"key":"e_1_3_4_103_1","unstructured":"G\u00fcnther B L\u00f6scher F Eickhoff K. inventors; Novaliq GmbH assignee. Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases. United States patent US 11 723 861. 2023 Aug 15."},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2021.0102"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2019.06.008"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2014.05.009"},{"key":"e_1_3_4_107_1","unstructured":"G\u00fcnther B Theisinger B Theisinger S et al. Compositions comprising mixtures of semifluorinated alkanes. United States patent US 10 369 117. 2019 Aug 6. Available from: https:\/\/patents.google.com\/patent\/US10369117B2\/en"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002633"},{"key":"e_1_3_4_109_1","first-page":"10","article-title":"Long-term safety and efficacy of a water-free cyclosporine 0.1% ophthalmic solution for treatment of dry eye disease: ESSENCE-2 OLE","volume":"13","author":"Wirta DL","year":"2022","unstructured":"Wirta DL, Galor A, Aune CA, et al. Long-term safety and efficacy of a water-free cyclosporine 0.1% ophthalmic solution for treatment of dry eye disease: ESSENCE-2 OLE. Cornea. 2022 May;13:10\u201397.","journal-title":"Cornea"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.01.024"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001199"},{"issue":"13","key":"e_1_3_4_112_1","first-page":"4961","article-title":"Toxicity of ocular preservatives and buffering agents on the ocular surface (corneal and conjunctival epithelium)","volume":"47","author":"Epstein SP","year":"2006","unstructured":"Epstein SP, Ahdoot M, Koonapareddy C, et al. Toxicity of ocular preservatives and buffering agents on the ocular surface (corneal and conjunctival epithelium). Invest Ophthalmol Visual Sci. 2006 May 1;47(13):4961\u2013.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.1989.tb00512.x"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011956327987"},{"key":"e_1_3_4_115_1","first-page":"2195","article-title":"Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model","volume":"18","author":"Liang H","year":"2012","unstructured":"Liang H, Baudouin C, Daull P, et al. Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model. Mol Vis. 2012 Aug 8;18:2195.","journal-title":"Mol Vis"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1367-0484(98)80026-X"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210701700311"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(92)31847-0"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.26717\/BJSTR.2022.45.007130"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0939-6411(01)00246-6"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.078386"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99892-8"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1128\/aem.02119-23"},{"issue":"1","key":"e_1_3_4_124_1","first-page":"40","article-title":"EyeSol: a novel topical ocular drug delivery system for poorly soluble drugs","volume":"13","author":"Scherer D","year":"2013","unstructured":"Scherer D, Alvarez-Gonzalez E, Pettigrew T. EyeSol: a novel topical ocular drug delivery system for poorly soluble drugs. Drug Devel Delivery. 2013;13(1):40\u201344.","journal-title":"Drug Devel Delivery"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2015.0048"},{"key":"e_1_3_4_126_1","unstructured":"Agarwal PA. Application of semifluorinated alkanes in dry eye therapy. [Doctoral dissertation] University of Auckland."},{"key":"e_1_3_4_127_1","unstructured":"Krosser S et al. Pharmacokinetics and distribution of perfluorobutylpentane a novel eye drop vehicle in rabbits after topical administration. Paper presented at: tear film and ocular surface society congress. Venice Italy; 2024 Oct 30 Nov 2."},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700224"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318191b870"},{"issue":"2","key":"e_1_3_4_130_1","first-page":"136","article-title":"Assessment of lipid layer thickness of tear film in the diagnosis of dry-eye syndrome in children after the hematopoietic stem cell transplantation","volume":"113","author":"Kurpi\u0144ska M","year":"2011","unstructured":"Kurpi\u0144ska M, Gorczy\u0144ska E, Owoc-Lempach J, et al. Assessment of lipid layer thickness of tear film in the diagnosis of dry-eye syndrome in children after the hematopoietic stem cell transplantation. Klinika Oczna\/Acta Ophthalmologica Polonica. 2011 Jan 1;113(2):136\u2013140.","journal-title":"Klinika Oczna\/Acta Ophthalmologica Polonica"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006324-199701000-00014"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2023.0709"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30637-4"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70138-6"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.opx.0000171818.01353.8c"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.icl.0000247638.50568.c0"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2017.0042"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-105137"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.5301\/EJO.5000952"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.09.012"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S392315"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.03.050"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2024.0101"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-024-06688-3"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S228070"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12370"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12898"},{"key":"e_1_3_4_148_1","unstructured":"Restasis USPI Abbvie. 2017 [cited 2025 Jan 14]. Available from: https:\/\/www.rxabbvie.com\/pdf\/restasis_pi.pdf"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2015.0664"},{"key":"e_1_3_4_150_1","unstructured":"EMEA. Assessment report (EMA\/CHMP\/473489\/2014): IKERVIS. 2015."},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S226168"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2025.2522947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:08:54Z","timestamp":1762254534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2025.2522947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":149,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/17425247.2025.2522947"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2025.2522947","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}